Catyalyst Pharmaceutical (CPRX) Posts Narrower than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.38 --0%
Revenue Growth %: +5.9%
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +5.9%
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q1 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
- Morgan Stanley Resumes Global Payments (GPN) at Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
